Do analysts prefer FTRE or VMD?

Fortrea presently has a consensus price target of $17.45, suggesting a potential upside of 0.98%. Given Fortrea's stronger consensus rating and higher possible upside, equities research analysts clearly believe Fortrea is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fortrea 1 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.36 Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor FTRE or VMD?

In the previous week, Fortrea and Fortrea both had 2 articles in the media. Fortrea's average media sentiment score of 0.00 equaled Viemed Healthcare'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend INNV or VMD?

InnovAge presently has a consensus target price of $7.00, indicating a potential downside of 41.62%. Given InnovAge's higher possible upside, research analysts clearly believe InnovAge is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InnovAge 2 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.33 Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor INNV or VMD?

In the previous week, Viemed Healthcare had 1 more articles in the media than InnovAge. MarketBeat recorded 2 mentions for Viemed Healthcare and 1 mentions for InnovAge. InnovAge's average media sentiment score of 0.00 equaled Viemed Healthcare'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate TDOC or VMD?

Teladoc Health currently has a consensus price target of $7.43, suggesting a potential downside of 19.11%. Given Teladoc Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Teladoc Health is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teladoc Health 1 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.24 Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to TDOC or VMD?

In the previous week, Teladoc Health had 7 more articles in the media than Viemed Healthcare. MarketBeat recorded 9 mentions for Teladoc Health and 2 mentions for Viemed Healthcare. Teladoc Health's average media sentiment score of 0.49 beat Viemed Healthcare's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend VMD or CDNA?

CareDx has a consensus target price of $25.00, suggesting a potential downside of 14.35%. Given CareDx's higher possible upside, analysts plainly believe CareDx is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 CareDx 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer VMD or CDNA?

In the previous week, CareDx had 5 more articles in the media than Viemed Healthcare. MarketBeat recorded 7 mentions for CareDx and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.00 beat CareDx's score of -0.21 indicating that Viemed Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CareDx 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend PSNL or VMD?

Personalis currently has a consensus target price of $11.00, indicating a potential downside of 19.24%. Given Personalis' stronger consensus rating and higher possible upside, equities research analysts plainly believe Personalis is more favorable than Viemed Healthcare. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Personalis 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57 Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer PSNL or VMD?

In the previous week, Personalis had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 3 mentions for Personalis and 2 mentions for Viemed Healthcare. Personalis' average media sentiment score of 0.29 beat Viemed Healthcare's score of 0.00 indicating that Personalis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Personalis 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Viemed Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Viemed Healthcare (VMD) Competitors

$12.02 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$12.03 +0.01 (+0.08%)

As of 07/2/2026 05:40 PM Eastern

Compare

VMD vs. FTRE, INNV, TDOC, CDNA, and PSNL

Should you buy Viemed Healthcare stock or one of its competitors? MarketBeat compares Viemed Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Viemed Healthcare include Fortrea (FTRE), InnovAge (INNV), Teladoc Health (TDOC), CareDx (CDNA), and Personalis (PSNL). These companies are all part of the "healthcare" industry.

How does Viemed Healthcare compare to Fortrea?

Fortrea (NASDAQ:FTRE) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

In the previous week, Fortrea and Fortrea both had 2 articles in the media. Fortrea's average media sentiment score of 0.00 equaled Viemed Healthcare'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Fortrea has a beta of 2.03, suggesting that its stock price is 103% more volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

Viemed Healthcare has a net margin of 5.20% compared to Fortrea's net margin of -16.50%. Viemed Healthcare's return on equity of 10.52% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Viemed Healthcare	5.20%	10.52%	7.60%

Viemed Healthcare has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.71B	0.60	-$986.20M	-$4.91	N/A
Viemed Healthcare	$270.28M	1.71	$14.93M	$0.37	32.49

74.2% of Viemed Healthcare shares are held by institutional investors. 0.7% of Fortrea shares are held by insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Fortrea presently has a consensus price target of $17.45, suggesting a potential upside of 0.98%. Given Fortrea's stronger consensus rating and higher possible upside, equities research analysts clearly believe Fortrea is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Viemed Healthcare beats Fortrea on 9 of the 14 factors compared between the two stocks.

How does Viemed Healthcare compare to InnovAge?

InnovAge (NASDAQ:INNV) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

InnovAge has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

12.3% of InnovAge shares are held by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are held by institutional investors. 1.0% of InnovAge shares are held by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Viemed Healthcare has a net margin of 5.20% compared to InnovAge's net margin of -1.22%. Viemed Healthcare's return on equity of 10.52% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-1.22%	-4.73%	-2.20%
Viemed Healthcare	5.20%	10.52%	7.60%

InnovAge presently has a consensus target price of $7.00, indicating a potential downside of 41.62%. Given InnovAge's higher possible upside, research analysts clearly believe InnovAge is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Viemed Healthcare has lower revenue, but higher earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$853.70M	1.91	-$30.31M	-$0.09	N/A
Viemed Healthcare	$270.28M	1.71	$14.93M	$0.37	32.49

In the previous week, Viemed Healthcare had 1 more articles in the media than InnovAge. MarketBeat recorded 2 mentions for Viemed Healthcare and 1 mentions for InnovAge. InnovAge's average media sentiment score of 0.00 equaled Viemed Healthcare'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Viemed Healthcare beats InnovAge on 11 of the 14 factors compared between the two stocks.

How does Viemed Healthcare compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Teladoc Health has a beta of 2.1, meaning that its stock price is 110% more volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market.

Viemed Healthcare has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.66	-$200.32M	-$0.97	N/A
Viemed Healthcare	$270.28M	1.71	$14.93M	$0.37	32.49

Teladoc Health currently has a consensus price target of $7.43, suggesting a potential downside of 19.11%. Given Teladoc Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Teladoc Health is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.24
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Viemed Healthcare has a net margin of 5.20% compared to Teladoc Health's net margin of -6.81%. Viemed Healthcare's return on equity of 10.52% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-6.81%	-11.45%	-5.54%
Viemed Healthcare	5.20%	10.52%	7.60%

In the previous week, Teladoc Health had 7 more articles in the media than Viemed Healthcare. MarketBeat recorded 9 mentions for Teladoc Health and 2 mentions for Viemed Healthcare. Teladoc Health's average media sentiment score of 0.49 beat Viemed Healthcare's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are held by institutional investors. 0.7% of Teladoc Health shares are held by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Teladoc Health and Viemed Healthcare tied by winning 8 of the 16 factors compared between the two stocks.

How does Viemed Healthcare compare to CareDx?

Viemed Healthcare (NASDAQ:VMD) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Viemed Healthcare has a net margin of 5.20% compared to CareDx's net margin of -2.01%. Viemed Healthcare's return on equity of 10.52% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	5.20%	10.52%	7.60%
CareDx	-2.01%	-2.65%	-1.96%

In the previous week, CareDx had 5 more articles in the media than Viemed Healthcare. MarketBeat recorded 7 mentions for CareDx and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 0.00 beat CareDx's score of -0.21 indicating that Viemed Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CareDx	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Viemed Healthcare has higher earnings, but lower revenue than CareDx. CareDx is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.71	$14.93M	$0.37	32.49
CareDx	$412.82M	3.65	-$21.35M	-$0.16	N/A

74.2% of Viemed Healthcare shares are owned by institutional investors. 20.0% of Viemed Healthcare shares are owned by company insiders. Comparatively, 2.4% of CareDx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Viemed Healthcare has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market. Comparatively, CareDx has a beta of 2.43, indicating that its share price is 143% more volatile than the broader market.

CareDx has a consensus target price of $25.00, suggesting a potential downside of 14.35%. Given CareDx's higher possible upside, analysts plainly believe CareDx is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Viemed Healthcare beats CareDx on 9 of the 15 factors compared between the two stocks.

How does Viemed Healthcare compare to Personalis?

Personalis (NASDAQ:PSNL) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

Personalis currently has a consensus target price of $11.00, indicating a potential downside of 19.24%. Given Personalis' stronger consensus rating and higher possible upside, equities research analysts plainly believe Personalis is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Viemed Healthcare has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Personalis	$64.52M	22.11	-$81.27M	-$1.02	N/A
Viemed Healthcare	$270.28M	1.71	$14.93M	$0.37	32.49

Personalis has a beta of 2.24, indicating that its stock price is 124% more volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

Viemed Healthcare has a net margin of 5.20% compared to Personalis' net margin of -148.11%. Viemed Healthcare's return on equity of 10.52% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Personalis	-148.11%	-43.52%	-32.92%
Viemed Healthcare	5.20%	10.52%	7.60%

In the previous week, Personalis had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 3 mentions for Personalis and 2 mentions for Viemed Healthcare. Personalis' average media sentiment score of 0.29 beat Viemed Healthcare's score of 0.00 indicating that Personalis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Personalis	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Viemed Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

61.9% of Personalis shares are held by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are held by institutional investors. 4.2% of Personalis shares are held by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Viemed Healthcare beats Personalis on 9 of the 16 factors compared between the two stocks.

Get Viemed Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VMD vs. The Competition

Export

Metric	Viemed Healthcare	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$460.81M	$8.69B	$7.16B	$12.48B
Dividend Yield	N/A	2.45%	2.66%	6.52%
P/E Ratio	32.49	16.55	28.02	24.70
Price / Sales	1.71	6.06	540.37	99.49
Price / Cash	10.44	18.11	49.26	57.09
Price / Book	3.18	3.53	10.96	6.46
Net Income	$14.93M	$226.25M	$3.57B	$337.01M
7 Day Performance	3.35%	1.50%	2.12%	1.69%
1 Month Performance	20.56%	-0.23%	5.25%	3.81%
1 Year Performance	67.76%	-0.49%	33.29%	23.90%

Viemed Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VMD Viemed Healthcare	2.0868 of 5 stars	$12.02 flat	N/A	+67.8%	$460.81M	$270.28M	32.49	1,382
FTRE Fortrea	1.8106 of 5 stars	$17.40 -0.7%	$17.45 +0.3%	+230.7%	$1.66B	$2.72B	N/A	14,300	Analyst Downgrade Gap Up
INNV InnovAge	1.5081 of 5 stars	$11.85 +2.1%	$7.00 -40.9%	+170.7%	$1.58B	$853.70M	N/A	2,440	News Coverage High Trading Volume
TDOC Teladoc Health	1.0596 of 5 stars	$8.53 -1.9%	$7.43 -12.8%	+11.6%	$1.57B	$2.53B	N/A	5,600	News Coverage Gap Down
CDNA CareDx	1.0666 of 5 stars	$28.50 -2.7%	$25.00 -12.3%	+52.1%	$1.51B	$379.80M	N/A	740	Insider Trade Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VMD) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Viemed Healthcare (VMD) Competitors

VMD vs. FTRE, INNV, TDOC, CDNA, and PSNL

How does Viemed Healthcare compare to Fortrea?

Summary

How does Viemed Healthcare compare to InnovAge?

Summary

How does Viemed Healthcare compare to Teladoc Health?

Summary

How does Viemed Healthcare compare to CareDx?

Summary

How does Viemed Healthcare compare to Personalis?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VMD vs. The Competition

Viemed Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Viemed Healthcare (VMD) Competitors

VMD vs. FTRE, INNV, TDOC, CDNA, and PSNL

How does Viemed Healthcare compare to Fortrea?

Does the media favor FTRE or VMD?

Which has more volatility & risk, FTRE or VMD?

Is FTRE or VMD more profitable?

Which has preferable valuation & earnings, FTRE or VMD?

Do institutionals and insiders hold more shares of FTRE or VMD?

Do analysts prefer FTRE or VMD?

Summary

How does Viemed Healthcare compare to InnovAge?

Which has more risk and volatility, INNV or VMD?

Do institutionals and insiders believe in INNV or VMD?

Is INNV or VMD more profitable?

Do analysts recommend INNV or VMD?

Which has better valuation and earnings, INNV or VMD?

Does the media favor INNV or VMD?

Summary

How does Viemed Healthcare compare to Teladoc Health?

Which has more risk and volatility, TDOC or VMD?

Which has preferable valuation & earnings, TDOC or VMD?

Do analysts rate TDOC or VMD?

Is TDOC or VMD more profitable?

Does the media refer more to TDOC or VMD?

Do institutionals & insiders hold more shares of TDOC or VMD?

Summary

How does Viemed Healthcare compare to CareDx?

Is VMD or CDNA more profitable?

Does the media prefer VMD or CDNA?

Which has better valuation and earnings, VMD or CDNA?

Do institutionals & insiders hold more shares of VMD or CDNA?

Which has more volatility & risk, VMD or CDNA?

Do analysts recommend VMD or CDNA?

Summary

How does Viemed Healthcare compare to Personalis?

Do analysts recommend PSNL or VMD?

Which has preferable valuation and earnings, PSNL or VMD?

Which has more volatility and risk, PSNL or VMD?

Is PSNL or VMD more profitable?

Does the media prefer PSNL or VMD?

Do institutionals and insiders have more ownership in PSNL or VMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VMD vs. The Competition

Viemed Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools